Product Information
VIIBRYD 20 MG TABLET is a brand product labeled by Allergan, Inc., priced at $12.1888 per EA under NDC 00456112030. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Jan 21, 2011. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the vilazodone hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
20 mg/1
Manufacturer
Allergan, Inc.NDC
00456112030
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
VILAZODONE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA022567FDA Approved
1/21/2011
TE Code
AB
On Market Since
4/29/2011
Price Statistics
The NADAC for VIIBRYD 20 MG TABLET has been published 665 times since Nov 28, 2013, and over the history we have for it it has risen 149.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $12.1888 per EA |
|---|---|
| All-time high | $12.2052 (May 13, 2026) |
| All-time low | $4.8920 (Nov 28, 2013) |
| 52-week high | $12.2052 |
| 52-week low | $11.6213 |
| Median price | $9.1335 |
| Average price | $8.8095 |
| Largest weekly change | +15.0% (Jan 14, 2015) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 94% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of VIIBRYD 20 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for VIIBRYD 20 MG TABLET, manufactured by Allergan, Inc., is $12.1888 per EA (NDC 00456112030), effective Aug 19, 2026.
How has the price of VIIBRYD 20 MG TABLET changed over time?
Over the history we have for it, the NADAC for VIIBRYD 20 MG TABLET has risen 149.2%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for VIIBRYD 20 MG TABLET?
Since Nov 28, 2013, the NADAC for VIIBRYD 20 MG TABLET has ranged from a low of $4.8920 (Nov 28, 2013) to a high of $12.2052 (May 13, 2026), with a median of $9.1335 per EA.
Are there cheaper alternatives to VIIBRYD 20 MG TABLET?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, VILAZODONE HCL 20 MG TABLET, is $0.7349 per EA — about 94% below VIIBRYD 20 MG TABLET.
Who manufactures VIIBRYD 20 MG TABLET?
VIIBRYD 20 MG TABLET (NDC 00456112030) is labeled by Allergan, Inc., and CMS classifies it as a brand product.